Your browser doesn't support javascript.
loading
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide.
Chen, Jinghong; Zuo, Zhixiang; Gao, Yan; Yao, Xiaosai; Guan, Peiyong; Wang, Yali; Li, Zhimei; Liu, Zhilong; Hong, Jing Han; Deng, Peng; Chan, Jason Yongsheng; Cheah, Daryl Ming Zhe; Lim, Jingquan; Chai, Kelila Xin Ye; Chia, Burton Kuan Hui; Pang, Jane Wan Lu; Koh, Joanna; Huang, Dachuan; He, Haixia; Sun, Yichen; Liu, Lizhen; Liu, Shini; Huang, Yuhua; Wang, Xiaoxiao; You, Hua; Saraf, Sahil Ajit; Grigoropoulos, Nicholas Francis; Li, Xiaoqiu; Bei, Jinxin; Kang, Tiebang; Lim, Soon Thye; Teh, Bin Tean; Huang, Huiqiang; Ong, Choon Kiat; Tan, Jing.
Affiliation
  • Chen J; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Zuo Z; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Gao Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Yao X; Institute of Molecular and Cell Biology, Singapore, Singapore.
  • Guan P; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Wang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Li Z; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • Liu Z; Department of Hematology, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Hong JH; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
  • Deng P; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Chan JY; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Cheah DMZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
  • Lim J; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Chai KXY; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Chia BKH; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Pang JWL; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Koh J; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Huang D; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.
  • He H; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Sun Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Liu L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Liu S; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Huang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Wang X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • You H; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Saraf SA; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.
  • Grigoropoulos NF; Department of Anatomical Pathology, Singapore General Hospital, Singapore, Singapore.
  • Li X; Department of Hematology, Singapore General Hospital, Singapore, Singapore.
  • Bei J; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Kang T; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Lim ST; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-Sen University Cancer Center, 651 East Dongfeng Road, Guangzhou, 510060, China.
  • Teh BT; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Huang H; Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, 11 Hospital Drive, Singapore, 169610, Singapore.
  • Ong CK; Institute of Molecular and Cell Biology, Singapore, Singapore.
  • Tan J; Cancer and Stem Cell Biology Program, Duke-NUS Medical School, Singapore, Singapore.
Clin Epigenetics ; 15(1): 19, 2023 02 06.
Article in En | MEDLINE | ID: mdl-36740715
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Epigenetics Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, T-Cell, Peripheral / Neoplasms Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Clin Epigenetics Year: 2023 Document type: Article Affiliation country: China Country of publication: Germany